DE3583765D1 - Hydantoinderivate und diese enthaltende pharmazeutische zusammensetzungen. - Google Patents
Hydantoinderivate und diese enthaltende pharmazeutische zusammensetzungen.Info
- Publication number
- DE3583765D1 DE3583765D1 DE8585810100T DE3583765T DE3583765D1 DE 3583765 D1 DE3583765 D1 DE 3583765D1 DE 8585810100 T DE8585810100 T DE 8585810100T DE 3583765 T DE3583765 T DE 3583765T DE 3583765 D1 DE3583765 D1 DE 3583765D1
- Authority
- DE
- Germany
- Prior art keywords
- hydanto
- derivatives
- pharmaceutical compositions
- compositions containing
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59045278A JPH062748B2 (ja) | 1984-03-08 | 1984-03-08 | 新規ヒダントイン誘導体及び該化合物を有効成分として含有する医薬組成物 |
JP59241439A JPH0686436B2 (ja) | 1984-11-15 | 1984-11-15 | 新規ヒダントイン誘導体及び該化合物を含有する医薬組成物 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3583765D1 true DE3583765D1 (de) | 1991-09-19 |
Family
ID=26385246
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8585810100T Expired - Fee Related DE3583765D1 (de) | 1984-03-08 | 1985-03-08 | Hydantoinderivate und diese enthaltende pharmazeutische zusammensetzungen. |
Country Status (6)
Country | Link |
---|---|
US (1) | US4647574A (de) |
EP (1) | EP0160618B1 (de) |
KR (1) | KR930001835B1 (de) |
AU (1) | AU578068B2 (de) |
DE (1) | DE3583765D1 (de) |
ES (1) | ES8609272A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2678499B2 (ja) * | 1989-08-09 | 1997-11-17 | 日本臓器製薬 株式会社 | 尿毒症毒素低下剤 |
US5681843A (en) * | 1994-12-20 | 1997-10-28 | Nippon Zoki Pharmaceutical Co., Ltd. | Parabanic acid derivatives |
US5912261A (en) * | 1994-12-20 | 1999-06-15 | Nippon Zoki Pharmaceutical Co., Ltd. | Carboxyalkyl heterocyclic derivatives |
US6197806B1 (en) | 1995-12-20 | 2001-03-06 | Nippon Zoki Pharmaceutical Co., Ltd. | Eliminating agent for activated oxygen and free radicals |
JPH10182460A (ja) * | 1996-12-27 | 1998-07-07 | Nippon Zoki Pharmaceut Co Ltd | 3−デオキシグルコソン生成阻害剤 |
KR19980076014A (ko) * | 1997-04-04 | 1998-11-16 | 성재갑 | 용액상 및 고체상 반응을 이용한 하이덴토인 유도체의 합성방법 |
AU754989B2 (en) | 1998-11-16 | 2002-11-28 | Nippon Zoki Pharmaceutical Co., Ltd. | A therapeutic agent for intractable vasculitis |
DE19934231B4 (de) | 1999-07-21 | 2004-02-19 | Bayer Ag | Verfahren zur Herstellung von 1-substituierten 5-Hydroxy-imidazolin-2,4-dionen und 1-substituierten 5-Alkoxy-imidazolin-2,4-dionen |
JP4711523B2 (ja) | 2001-02-13 | 2011-06-29 | 日本臓器製薬株式会社 | 低アルブミン血症改善剤 |
TWI353979B (en) * | 2002-04-10 | 2011-12-11 | Nippon Zoki Pharmaceutical Co | Novel crystal form of 5-hydroxy-1-methylhydantoin |
US20060241163A1 (en) * | 2005-04-20 | 2006-10-26 | Kaoru Okamoto | Optically active (S)-hydantoin derivative |
US20060241162A1 (en) * | 2005-04-20 | 2006-10-26 | Kaoru Okamoto | Optically active (R)-hydantoin derivative |
US11090313B2 (en) | 2010-05-20 | 2021-08-17 | University Of Iowa Research Foundation | Methods for inhibiting muscle atrophy |
JP5808797B2 (ja) | 2010-05-20 | 2015-11-10 | ユニバーシティ オブ アイオワ リサーチ ファウンデーション | 筋萎縮を阻害するための方法 |
AU2012268036B2 (en) | 2011-06-06 | 2017-04-06 | THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF STATE OF THE DEPARTMENT OF VETERANS AFFAIRS | Methods of inhibiting muscle atrophy |
CN117100744B (zh) * | 2023-10-11 | 2024-04-02 | 吉林大学 | 1-mh在制备减肥、降血脂、治疗脂肪肝和糖尿病的药物中的应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2553055A (en) * | 1946-11-07 | 1951-05-15 | Dow Chemical Co | Synthesis of 5-(sec.-butyl) hydantion |
NL292187A (de) * | 1962-05-02 | |||
US3395153A (en) * | 1964-12-16 | 1968-07-30 | United States Borax Chem | 3, 5-dialkylhydantoins |
CH523279A (de) * | 1968-11-11 | 1972-05-31 | Ciba Geigy Ag | Verfahren zur Herstellung von neuen Diglycidylverbindungen von N-heterocyclischen Verbindungen und deren Verwendung |
US3696198A (en) * | 1970-04-02 | 1972-10-03 | Frederick J Mccarty | Treatment of anoxia with 3,5-dialkyl hydantoins |
US3847933A (en) * | 1970-12-09 | 1974-11-12 | Exxon Research Engineering Co | Acid catalyzed alkylation of hydantoin |
CA999855A (en) * | 1972-09-18 | 1976-11-16 | Societa' Farmaceutici Italia S.P.A. | Process for the preparation of tetracyclines derivatives in the 7 position |
IE46672B1 (en) * | 1977-03-18 | 1983-08-24 | Kanegafuchi Chemical Ind | Process for preparing 5-(4-hydroxyphenyl)hydantoin |
GB1600880A (en) * | 1978-05-23 | 1981-10-21 | Lilly Industries Ltd | Pharmaceutical compositions comprising hydantoin derivatives |
US4198423A (en) * | 1979-03-20 | 1980-04-15 | Basf Aktiengesellschaft | 1,3-Bis-(trihalomethylsulfenyl)-imidazoline-2,4-diones |
-
1985
- 1985-02-26 AU AU39172/85A patent/AU578068B2/en not_active Ceased
- 1985-03-04 KR KR1019850001348A patent/KR930001835B1/ko not_active IP Right Cessation
- 1985-03-07 ES ES541029A patent/ES8609272A1/es not_active Expired
- 1985-03-08 DE DE8585810100T patent/DE3583765D1/de not_active Expired - Fee Related
- 1985-03-08 EP EP85810100A patent/EP0160618B1/de not_active Expired - Lifetime
- 1985-03-08 US US06/709,861 patent/US4647574A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
KR930001835B1 (ko) | 1993-03-15 |
ES8609272A1 (es) | 1986-07-16 |
EP0160618A1 (de) | 1985-11-06 |
ES541029A0 (es) | 1986-07-16 |
KR850006187A (ko) | 1985-10-02 |
US4647574A (en) | 1987-03-03 |
EP0160618B1 (de) | 1991-08-14 |
AU3917285A (en) | 1985-09-12 |
AU578068B2 (en) | 1988-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69014351T2 (de) | Pyridincarbonsäureamid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen. | |
DE3486441D1 (de) | 3-Hydroxypyrid-4-one und pharmazeutische Zusammensetzungen | |
IT1232677B (it) | Composizione farmaceutica contenente ranitidina | |
DE69015842D1 (de) | Nicotinsäurederivate und diese enthaltende pharmazeutische Zusammensetzungen. | |
IT8820386A0 (it) | Composizioni farmaceutiche orosolubili contenti acetilcisteina. | |
DE3583765D1 (de) | Hydantoinderivate und diese enthaltende pharmazeutische zusammensetzungen. | |
FI893643A0 (fi) | Farmaceutiska kompositioner. | |
DE3579730D1 (de) | Eisen-3-hydroxypyron- oder 3-hydroxypyridon-komplexe und diese enthaltende pharmazeutische zusammensetzungen. | |
DE3682083D1 (de) | Pharmazeutische zusammensetzungen. | |
DE68909501D1 (de) | Hydroxyalkylcystein-derivate und diese enthaltende expectoranzien. | |
DE3674040D1 (de) | Pharmazeutische zusammensetzungen. | |
IT1213453B (it) | Composizione farmaceutica. | |
DE3576505D1 (de) | 3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen. | |
DE3578597D1 (de) | 4-phenylphthalazin-derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen. | |
DE68909555D1 (de) | Pyridylketoximether-verbindung und diese enthaltende pharmazeutische zusammensetzung. | |
DE68907609D1 (de) | Arzneimittelzusammensetzung. | |
DE3669656D1 (de) | Azanaphthalene enthaltende arzneimittelzusammensetzungen. | |
DE3671630D1 (de) | Glycero-3(2)-phospho-l-serinderivate und diese enthaltende pharmazeutischen praeparate. | |
DE3871159D1 (de) | Pharmazeutische und tieraerztliche zusammensetzungen. | |
DE68902056D1 (de) | 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung. | |
KR900700471A (ko) | 신규의 2,3-티오모르폴린디온-2-옥심유도체, 이들을 함유하는 약제학적 조성물 및 제법 | |
ATE66213T1 (de) | Hydantoinderivate und diese enthaltende pharmazeutische zusammensetzungen. | |
DE3667915D1 (de) | Pharmazeutische zusammensetzung. | |
IT1224244B (it) | Composizione farmaceutica anoressizzante comprendente 5-idrossitrpofano | |
ATE50995T1 (de) | 3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |